Radius Health, Inc. (RDUS)
USD 29.06
(0.24%)
USD 29.06
(0.24%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 265.92 Million USD | 1.01% |
| 2022 | 263.25 Million USD | 8.58% |
| 2021 | 242.46 Million USD | 29.05% |
| 2020 | 187.87 Million USD | -30.28% |
| 2019 | 269.46 Million USD | -8.62% |
| 2018 | 294.87 Million USD | 9.31% |
| 2017 | 269.75 Million USD | 45.85% |
| 2016 | 184.94 Million USD | 86.67% |
| 2015 | 99.07 Million USD | 66.82% |
| 2014 | 59.39 Million USD | -11.83% |
| 2013 | 67.36 Million USD | 4.56% |
| 2012 | 64.43 Million USD | 55.22% |
| 2011 | 41.5 Million USD | 88628.57% |
| 2010 | 46.78 Thousand USD | 46.23% |
| 2009 | 31.99 Thousand USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 265.92 Million USD | 1.01% |
| 2023 Q1 | 63.95 Million USD | -0.42% |
| 2023 Q2 | 68.52 Million USD | 7.15% |
| 2023 Q3 | 69.21 Million USD | 1.01% |
| 2023 Q4 | 63.1 Million USD | -8.83% |
| 2022 Q4 | 64.22 Million USD | -7.23% |
| 2022 Q1 | 52.74 Million USD | -26.25% |
| 2022 Q2 | 60.56 Million USD | 14.82% |
| 2022 FY | 263.25 Million USD | 8.58% |
| 2022 Q3 | 69.23 Million USD | 14.33% |
| 2021 Q2 | 59.09 Million USD | -9.83% |
| 2021 Q3 | 68.99 Million USD | 16.75% |
| 2021 Q4 | 71.51 Million USD | 3.66% |
| 2021 Q1 | 65.53 Million USD | -9.19% |
| 2021 FY | 242.46 Million USD | 29.05% |
| 2020 Q1 | 75.44 Million USD | 7.29% |
| 2020 Q3 | 73.14 Million USD | -12.0% |
| 2020 Q4 | 72.17 Million USD | -1.33% |
| 2020 FY | 187.87 Million USD | -30.28% |
| 2020 Q2 | 83.11 Million USD | 10.17% |
| 2019 Q1 | 64.44 Million USD | -4.99% |
| 2019 Q2 | 67.29 Million USD | 4.42% |
| 2019 Q4 | 70.31 Million USD | 4.31% |
| 2019 Q3 | 67.4 Million USD | 0.17% |
| 2019 FY | 269.46 Million USD | -8.62% |
| 2018 Q1 | 70.87 Million USD | -3.75% |
| 2018 FY | 294.87 Million USD | 9.31% |
| 2018 Q4 | 67.83 Million USD | -3.74% |
| 2018 Q3 | 70.46 Million USD | -17.78% |
| 2018 Q2 | 85.7 Million USD | 20.92% |
| 2017 FY | 269.75 Million USD | 45.85% |
| 2017 Q4 | 73.63 Million USD | 7.15% |
| 2017 Q3 | 68.72 Million USD | -1.51% |
| 2017 Q2 | 69.77 Million USD | 21.08% |
| 2017 Q1 | 57.62 Million USD | 8.64% |
| 2016 Q4 | 53.04 Million USD | 13.6% |
| 2016 FY | 184.94 Million USD | 86.67% |
| 2016 Q1 | 41.12 Million USD | 21.64% |
| 2016 Q3 | 46.69 Million USD | 5.92% |
| 2016 Q2 | 44.08 Million USD | 7.18% |
| 2015 FY | 99.07 Million USD | 66.82% |
| 2015 Q2 | 22.27 Million USD | 36.55% |
| 2015 Q1 | 16.31 Million USD | -5.12% |
| 2015 Q3 | 26.67 Million USD | 19.73% |
| 2015 Q4 | 33.81 Million USD | 26.76% |
| 2014 Q1 | 11.85 Million USD | -13.16% |
| 2014 FY | 59.39 Million USD | -11.83% |
| 2014 Q4 | 17.19 Million USD | 3.26% |
| 2014 Q3 | 16.65 Million USD | 21.66% |
| 2014 Q2 | 13.68 Million USD | 15.45% |
| 2013 Q2 | 17.68 Million USD | -6.26% |
| 2013 Q3 | 17.16 Million USD | -2.94% |
| 2013 Q4 | 13.65 Million USD | -20.46% |
| 2013 FY | 67.36 Million USD | 4.56% |
| 2013 Q1 | 18.86 Million USD | -4.15% |
| 2012 Q4 | 19.68 Million USD | 22.32% |
| 2012 Q1 | 11.97 Million USD | 18.47% |
| 2012 Q2 | 16.67 Million USD | 39.23% |
| 2012 Q3 | 16.09 Million USD | -3.52% |
| 2012 FY | 64.43 Million USD | 55.22% |
| 2011 Q4 | 10.11 Million USD | 14.03% |
| 2011 Q1 | 10.14 Thousand USD | -59.87% |
| 2011 Q2 | 17.49 Million USD | 172413.06% |
| 2011 Q3 | 8.86 Million USD | -49.33% |
| 2011 FY | 41.5 Million USD | 88628.57% |
| 2010 Q3 | 6038.00 USD | 4.92% |
| 2010 Q2 | 5755.00 USD | -40.74% |
| 2010 FY | 46.78 Thousand USD | 46.23% |
| 2010 Q1 | 9711.00 USD | 93.72% |
| 2010 Q4 | 25.27 Thousand USD | 318.65% |
| 2009 FY | 31.99 Thousand USD | 0.0% |
| 2009 Q4 | 5013.00 USD | -20.73% |
| 2009 Q3 | 6324.00 USD | -4.51% |
| 2009 Q2 | 6623.00 USD | -52.8% |
| 2009 Q1 | 14.03 Thousand USD | 0.0% |
| 2008 Q3 | 7044.00 USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -3122.26% |
| Alpha Teknova, Inc. | 45.85 Million USD | -479.884% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -35.69% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -492.877% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -67.032% |
| Cosmos Health Inc. | 26.18 Million USD | -915.741% |
| Journey Medical Corporation | 54.59 Million USD | -387.103% |
| Embecta Corp. | 528.4 Million USD | 49.673% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 2.195% |
| Dynavax Technologies Corporation | 219.14 Million USD | -21.348% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 54.928% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 18.521% |
| PainReform Ltd. | 9.58 Million USD | -2674.718% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -1926.208% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -1926.208% |
| SCYNEXIS, Inc. | 51.84 Million USD | -412.901% |
| Safety Shot Inc | 12.1 Million USD | -2096.001% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -8564.474% |
| Procaps Group, S.A. | 199.47 Million USD | -33.313% |
| Theratechnologies Inc. | 72.75 Million USD | -265.508% |
| Harrow Health, Inc. | 89.97 Million USD | -195.565% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -2715.255% |
| Biofrontera Inc. | 39.95 Million USD | -565.505% |
| DURECT Corporation | 43.71 Million USD | -508.324% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 49.731% |
| Cronos Group Inc. | 96.7 Million USD | -174.979% |
| OptiNose, Inc. | 85.1 Million USD | -212.483% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -14.563% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -579.205% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 2881.393% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 15.345% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -2632.849% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -517.857% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -1821.187% |
| ProPhase Labs, Inc. | 37.85 Million USD | -602.549% |
| Phibro Animal Health Corporation | 260.29 Million USD | -2.163% |
| Procaps Group S.A. | 187.24 Million USD | -42.022% |
| Alvotech | 285.43 Million USD | 6.835% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -2606.656% |
| Viatris Inc. | 5.96 Billion USD | 95.543% |
| Rockwell Medical, Inc. | 15.37 Million USD | -1629.732% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -344.4% |
| SIGA Technologies, Inc. | 22.04 Million USD | -1106.409% |
| Tilray Brands, Inc. | 251.35 Million USD | -5.797% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -442.292% |
| Shineco, Inc. | 17.94 Million USD | -1381.66% |
| PetIQ, Inc. | 192.72 Million USD | -37.984% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -6562.987% |
| Incannex Healthcare Limited | 30.05 Million USD | -784.867% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 83.343% |
| Alimera Sciences, Inc. | 62.64 Million USD | -324.529% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -34776.3% |
| Assertio Holdings, Inc. | 368.58 Million USD | 27.851% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -4418.321% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -1393.267% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -1156.219% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1163.795% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -61.202% |
| Hempacco Co., Inc. | 7.59 Million USD | -3400.701% |
| Talphera, Inc. | 11.99 Million USD | -2117.184% |
| Alvotech | 285.43 Million USD | 6.835% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -88.985% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 22.897% |
| Currenc Group, Inc. | 24 Million USD | -1007.941% |
| Kamada Ltd. | 45.42 Million USD | -485.411% |
| Indivior PLC | 911 Million USD | 70.809% |
| Evoke Pharma, Inc. | 12.4 Million USD | -2042.922% |
| Flora Growth Corp. | 10.57 Million USD | -2413.744% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1163.795% |
| Evolus, Inc. | 189.75 Million USD | -40.14% |
| HUTCHMED (China) Limited | 436.23 Million USD | 39.039% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -72.531% |
| Akanda Corp. | 3.48 Million USD | -7533.943% |